We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lupin Unit, Novartis Wrap Up Hypertension Drug Dispute
Lupin Unit, Novartis Wrap Up Hypertension Drug Dispute
September 15, 2009
Novartis and a subsidiary of Indian drugmaker Lupin Pharmaceuticals have ended a longstanding patent dispute involving the hypertension drug Lotrel.